Antisense oligonucleotide modulators of serotonin receptor 2c and uses thereof
AssigneesShire Human Genetic Therapies, Inc., University of Kentucky
InventorsStefan Stamm, Manli Shen, Serene Josiah
Life of this patent
Estimating the term…
Abstract
The present invention provides, among other things, oligonucleotide modulators of human 5′-HT2C receptor (HTR2C) and improved methods and composition for treating HTR2C-related diseases, disorders or conditions based on such modulators. In particular, oligonucleotides modulators according to the invention target specific regions in the Exon V/Intron V junction of the human HTR2C pre-mRNA and drive expression of HTR2C Vb splice isoform, leading to increased generation of non-edited strong HTR2C receptor and enhanced serotonin receptor activity.
Claims21
An antisense oligonucleotide of 10-50 nucleotides in length comprising a sequence that permits specific hybridization to a target region of a human 5′-HT2C receptor (HTR2C) pre-mRNA under stringent conditions, wherein the target region comprises a nucleotide sequence 5′ UUGGCCAUAAGAAUUGCAGCGGCUAUGCUCAAUACU 3′ (SEQ ID NO:
- 1) and further wherein the stringent conditions comprise 50% formamide with 1 mg heparin at 42° C. with hybridization carried out overnight and a wash in 0.2×SSC at 65° C. for 15 minutes.
An antisense oligonucleotide of 10-50 nucleotides in length comprising a sequence at least 70% identical to 10 or more contiguous nucleotides that appear in 5′ AGUAUUGAGCAUAGCCGCUGCAAUUCUUAUGGCCAA 3′ (SEQ ID NO:
- 15).
9-14. (canceled)
(canceled)
25-26. (canceled)
Dependencies are inferred from the claim text.